Mitchell C. Posner to Adult
This is a "connection" page, showing publications Mitchell C. Posner has written about Adult.
Connection Strength
0.447
-
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
Score: 0.045
-
Perioperative Gemcitabine?+?Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial. Ann Surg Oncol. 2019 Dec; 26(13):4489-4497.
Score: 0.043
-
A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol. 2012 Feb; 19(2):384-91.
Score: 0.025
-
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Ann Surg Oncol. 2008 Jan; 15(1):158-64.
Score: 0.019
-
Effectiveness of the uChicago Health Inequity Classification System on surgical morbidity and mortality conference: A pilot study. Am J Surg. 2024 Oct; 236:115834.
Score: 0.015
-
Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacy. Am J Transplant. 2003 Mar; 3(3):312-7.
Score: 0.014
-
Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer. Surgery. 2001 Oct; 130(4):620-6; discussion 626-8.
Score: 0.013
-
Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma. Arch Surg. 2001 Jul; 136(7):737-42; discussion 743.
Score: 0.012
-
Surgical management of benign tumors of the liver. Int J Gastrointest Cancer. 2001; 30(3):141-6.
Score: 0.012
-
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
Score: 0.012
-
Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg. 2000 May; 135(5):530-4; discussion 534-5.
Score: 0.011
-
Apoptosis in esophageal cancer following induction chemoradiotherapy. J Surg Res. 1998 Sep; 79(1):20-4.
Score: 0.010
-
p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer. 1998 Jul 01; 83(1):7-18.
Score: 0.010
-
Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. Cancer J Sci Am. 1998 Jul-Aug; 4(4):237-46.
Score: 0.010
-
Interdisciplinary Oncology Education: a National Survey of Trainees and Program Directors in the United States. J Cancer Educ. 2018 06; 33(3):622-626.
Score: 0.010
-
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018 05 04; 9(1):1793.
Score: 0.010
-
Role of nutrition support during induction chemoradiation therapy in esophageal cancer. JPEN J Parenter Enteral Nutr. 1998 Jan-Feb; 22(1):18-21.
Score: 0.010
-
Chronic hepatitis C virus infection in humans: induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis. J Surg Res. 1997 May; 69(2):321-4.
Score: 0.009
-
Extremes of body mass index and postoperative complications after esophagectomy. Dis Esophagus. 2017 May 01; 30(5):1-6.
Score: 0.009
-
Doubling of 30-Day Mortality by 90 Days After Esophagectomy: A Critical Measure of Outcomes for Quality Improvement. Ann Surg. 2016 Feb; 263(2):286-91.
Score: 0.008
-
Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma. Cancer J Sci Am. 1995 Nov-Dec; 1(4):274-80.
Score: 0.008
-
Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience. Am Surg. 2015 Apr; 81(4):421-7.
Score: 0.008
-
Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J Natl Cancer Inst. 2014 Jul; 106(7).
Score: 0.008
-
Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014 May; 21(5):1520-9.
Score: 0.007
-
Prospective clinical trial of diagnostic peritoneal lavage to detect positive peritoneal cytology in patients with gastric cancer. J Surg Oncol. 2013 Jun; 107(8):794-8.
Score: 0.007
-
Peripheral pulmonary nodules: preoperative percutaneous needle localization with CT guidance. Radiology. 1992 Oct; 185(1):274-6.
Score: 0.007
-
A RAND/UCLA appropriateness study of the management of familial gastric cancer. Ann Surg Oncol. 2013 Feb; 20(2):533-41.
Score: 0.007
-
A phase II trial of continuous infusion cisplatin and 5-fluorouracil with oral calcium leucovorin in colorectal carcinoma. Am J Clin Oncol. 1992 Jun; 15(3):239-41.
Score: 0.007
-
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc. 2012 Feb; 75(2):332-8.
Score: 0.006
-
Non-invasive breast carcinoma. Breast Cancer Res Treat. 1992; 21(3):155-64.
Score: 0.006
-
MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant. 2011 Oct; 11(10):2110-22.
Score: 0.006
-
A phase I-II trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinoma. Am J Clin Oncol. 1990 Oct; 13(5):455-8.
Score: 0.006
-
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61.
Score: 0.006
-
Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol. 2011 Feb; 22(2):348-54.
Score: 0.006
-
The desmoid tumor. Not a benign disease. Arch Surg. 1989 Feb; 124(2):191-6.
Score: 0.005
-
Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers. Oral Oncol. 2007 Mar; 43(3):289-300.
Score: 0.004
-
Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum: what is now the appropriate distal resection margin? Surgery. 2005 Oct; 138(4):658-63; discussion 663-4.
Score: 0.004
-
Extrahepatic biliary tract injury: operative management plan. J Trauma. 1985 Sep; 25(9):833-7.
Score: 0.004
-
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J Clin Oncol. 2001 Jan 15; 19(2):289-98.
Score: 0.003
-
Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol. 2000 Apr; 7(3):188-92.
Score: 0.003
-
Thoracoscopic techniques for the management of intrathoracic metastases. Results. Surg Endosc. 1998 Jun; 12(6):842-5.
Score: 0.002
-
Efficacy of cisplatin, 5-fluorouracil, and paclitaxel regimen for carcinoma of the esophagus. Semin Oncol. 1997 Dec; 24(6 Suppl 19):S19-89-S19-92.
Score: 0.002
-
Comparative p53 mutational analysis of multiple primary cancers of the upper aerodigestive tract. Surgery. 1996 Jul; 120(1):45-53.
Score: 0.002
-
A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol. 1995 May; 95(5 Pt 2):1139-46.
Score: 0.002
-
Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies. J Clin Invest. 1995 Feb; 95(2):732-7.
Score: 0.002
-
Needle-localized thoracoscopic resection of indeterminate pulmonary nodules: impact on management of patients with malignant disease. Ann Surg Oncol. 1995 Jan; 2(1):49-55.
Score: 0.002
-
Induction with OKT3 and prostaglandin E1 in liver transplantation. Transplant Sci. 1994 Dec; 4 Suppl 1:S1-8.
Score: 0.002
-
Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1994 Dec 01; 30(5):1043-50.
Score: 0.002
-
Combined modality therapy for stage IIIA non-small cell carcinoma of the lung. Eur J Cancer. 1993; 29A(4):511-5.
Score: 0.002
-
Interstitial hypertension in human breast and colorectal tumors. Cancer Res. 1992 Nov 15; 52(22):6371-4.
Score: 0.002
-
Comparison of immune repertoires of Chinese and Philippine patients infected with Schistosoma japonicum. Infect Immun. 1991 Dec; 59(12):4698-700.
Score: 0.002
-
Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM). Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):787-91.
Score: 0.001